Black Diamond Therapeutics, Inc.
Ticker: BDTX
| Insider | Title |
|---|---|
| Alexander Mayweg | Director |
| Ali Behbahani | Director |
| Biotech Ag Bb | 10% or greater ownership |
| Bradley J Phd Bolzon | Director, 10% or greater ownership |
| Brent Hatzis-schoch | SEE REMARKS |
| David M. Epstein | SEE REMARKS, Director |
| Elizabeth Buck | CHIEF SCIENTIFIC OFFICER |
| Erika Jones | SEE REMARKS |
| Fang Ni | SEE REMARKS |
| Garry E Menzel | Director |
| Growth N V Biotech | 10% or greater ownership |
| Kapil Dhingra | Director |
| Mark A. Velleca | PRESIDENT CEO, Director |
| Prakash Raman | Director |
| Rajeev M. Shah | Director |
| Robert Alexander Ingram | Director |
| Samarth Kulkarni | Director |
| Sergey Yurasov | CHIEF MEDICAL OFFICER |
| Shannon Campbell | Director |
| Vantage I, L.p. Versant | 10% or greater ownership |
| Venture Capital Vi, L.p. Versant | 10% or greater ownership |
| Voyageurs I Parallel, L.p. Versant | 10% or greater ownership |
| Voyageurs I, L.p. Versant | 10% or greater ownership |
| Wendy L Dixon | Director |